Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma

European Journal of Surgical Oncology

Volumn 38, Issue 7, 2012, Pages 594-601

  Inarrairaegui M ^a,b   Pardo, F ^a   Bilbao, J I ^a   Rotellar, F ^a   Benito, A ^a   D'Avola, D ^a,b   Herrero, J I ^a,b   Rodriguez, M ^a   Marti P ^a   Zozaya, G ^a   Dominguez, I ^a   Quiroga, J ^a,b   Sangro, B ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Downstaging; Hepatocellular carcinoma; Liver radioembolization; Liver resection; Liver transplantation; Radical therapies

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; MACROSALB TC 99M; METHYLPREDNISOLONE; MICROSPHERE; PROTON PUMP INHIBITOR; RESIN; SPHERES; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; YTTRIUM 90;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOEMBOLIZATION; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICROSPHERES; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84862171820     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.02.189     Document Type: Article

References (30)

1. M. Varela, M. Reig, and M. de la Mata Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers Med Clin (Barc) 134 2010 569 576
2. J.M. Llovet, A.M. Di Bisceglie, and J. Bruix For the panel of experts in HCC-design clinical trials. Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
3. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
4. T.M. Pawlik, K.A. Delman, and J.N. Vauthey Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma Liver Transpl 11 2005 1086 1092 (Pubitemid 41341758)
5. A. Cucchetti, G. Ercolani, and M. Vivarelli Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis Liver Transpl 12 2006 966 971 (Pubitemid 43960373)
6. T. Livraghi, F. Meloni, and M. Di Stasi Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89 (Pubitemid 351171044)
7. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699 (Pubitemid 26079803)
8. J.I. Herrero, B. Sangro, and F. Pardo Liver transplantation in patients with hepatocellular carcinoma across Milan criteria Liver Transpl 14 2008 272 278 (Pubitemid 351425478)
9. UNOS. Adult and pediatric donor liver allocation algorithms. http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-8.pdf; [accessed on May 2011].
10. F.Y. Yao, L. Xiao, N.M. Bass, R. Kerlan, N.L. Ascher, and J.P. Roberts Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587 2596 (Pubitemid 47561609)
11. W.Y. Lau, and E.C. Lai Salvage surgery following downstaging of unresectable hepatocellular carcinoma-a strategy to increase resectability Ann Surg Oncol 14 2007 3301 3309 (Pubitemid 350160117)
12. F.Y. Yao, R.K. Kerlan Jr., and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
13. M. Ravaioli, G.L. Grazi, and F. Piscaglia Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
14. C. Toso, G. Mentha, N.M. Kneteman, and P. Majno The place of downstaging for hepatocellular carcinoma J Hepatol 52 2010 930 936
15. F.Y. Yao Expanding criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation-yes Sem Liv Dis 26 2006 239 247 (Pubitemid 44141931)
16. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928
17. L.M. Kulik, B. Atassi, and L. van Holsbeeck Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation J Surg Oncol 94 2006 572 586 (Pubitemid 44851918)
18. M. Iñarrairaegui, A. Martínez-Cuesta, and M. Rodriguez Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma Int J Radiat Oncol Biol Phys 77 2010 1441 1448
19. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver J Hepatol 35 2001 421 430 (Pubitemid 32844200)
20. A. Kennedy, D. Coldwell, B. Sangro, H. Wasan, and R. Salem Radioembolization for the treatment of liver tumors: general principles Am J Clin Oncol 2010 [Epub ahead of print]
21. S. Ho, W. Lau, T. Leung, M. Chan, P.J. Johnson, and A.K. Li Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer Eur J Nucl Med 24 1997 293 298 (Pubitemid 27165858)
22. R. Salem, R.J. Lewandowski, and M.F. Mulcahy Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 2010 52 64
23. D.Y. Kim, D.S. Kwon, R. Salem, C.K. Ma, and M.S. Abouljoud Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation J Gastrointest Surg 10 2006 413 416 (Pubitemid 43303837)
24. L.M. Kulik, M.F. Mulcahy, R.D. Hunter, A.A. Nemcek Jr., M.M. Abecassis, and R. Salem Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report Liver Transpl 11 2005 1127 1131 (Pubitemid 41341764)
25. G. N'Kontchou, A. Mahamoudi, and M. Aout Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 western patients with cirrhosis Hepatology 50 2009 1475 1483
26. W.T. Chen, G.Y. Chau, and W.Y. Lui Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome Eur J Surg Oncol 30 2004 414 420
27. R.J. Lewandowski, M.F. Mulcahy, and L.M. Kulik Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort Radiology 255 2010 955 965
28. J.M. Llovet, M.I. Real, and X. Montaña For the Barcelona Liver Cancer Group Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)
29. E. Vibert, D. Azoulay, and E. Hoti Progression of alpha-fetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor Am J Transplant 10 2010 129 137
30. R.A. Gaba, R.J. Lewandowski, and L.M. Kulik Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization Ann Surg Oncol 16 6 2009 Jun 1587 1596